These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 3378160)

  • 1. Effects of aminopeptidase inhibition on the half-lives of [125I]angiotensins in the cerebroventricles of the rat.
    Dewey AL; Wright JW; Hanesworth JM; Harding JW
    Brain Res; 1988 May; 448(2):369-72. PubMed ID: 3378160
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Binding, degradation and pressor activity of angiotensins II and III after aminopeptidase inhibition with amastatin and bestatin.
    Abhold RH; Sullivan MJ; Wright JW; Harding JW
    J Pharmacol Exp Ther; 1987 Sep; 242(3):957-62. PubMed ID: 3656120
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of aminopeptidase inhibitors on brain angiotensin metabolism and drinking in rats.
    Wright JW; Quirk WS; Hanesworth JM; Harding JW
    Brain Res; 1988 Feb; 441(1-2):215-20. PubMed ID: 3359232
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intracerebroventricularly infused [D-Arg1]angiotensin III, is superior to [D-Asp1]angiotensin II, as a pressor agent in rats.
    Wright JW; Roberts KA; Cook VI; Murray CE; Sardinia MF; Harding JW
    Brain Res; 1990 Apr; 514(1):5-10. PubMed ID: 2357530
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential effects of aminopeptidase inhibitors on angiotensin-induced pressor responses.
    Sullivan MJ; Harding JW; Wright JW
    Brain Res; 1988 Jul; 456(2):249-53. PubMed ID: 3208081
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of the aminopeptidase inhibitors amastatin and bestatin on angiotensin-evoked neuronal activity in rat brain.
    Harding JW; Felix D
    Brain Res; 1987 Oct; 424(2):299-304. PubMed ID: 3676828
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cerebroventricular and intravascular metabolism of [125I]angiotensins in rat.
    Harding JW; Yoshida MS; Dilts RP; Woods TM; Wright JW
    J Neurochem; 1986 Apr; 46(4):1292-7. PubMed ID: 3950629
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amastatin and bestatin-induced dipsogenicity in the Sprague-Dawley rat.
    Quirk WS; Harding JW; Wright JW
    Brain Res Bull; 1987 Jul; 19(1):145-7. PubMed ID: 3651838
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pressor responses to amastatin, bestatin and Plummer's inhibitors are suppressed by pretreatment with the angiotensin receptor antagonist sarthran.
    Batt CM; Klein EW; Harding JW; Wright JW
    Brain Res Bull; 1988 Nov; 21(5):731-5. PubMed ID: 3219604
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of aminopeptidase activity in the regulation of the pressor activity of circulating angiotensins.
    Ahmad S; Ward PE
    J Pharmacol Exp Ther; 1990 Feb; 252(2):643-50. PubMed ID: 1968973
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased blood pressure induced by central application of aminopeptidase inhibitors is angiotensinergic-dependent in normotensive and hypertensive rat strains.
    Jensen LL; Harding JW; Wright JW
    Brain Res; 1989 Jun; 490(1):48-55. PubMed ID: 2758329
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Brain angiotensin: critical role in the ongoing regulation of body fluid homeostasis and cardiovascular function.
    Harding JW; Jensen LL; Quirk WS; Dewey AL; Wright JW
    Peptides; 1989; 10(2):261-4. PubMed ID: 2755868
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Delayed cerebroventricular metabolism of [125I]angiotensins in the spontaneously hypertensive rat.
    Wright JW; Sullivan MJ; Bredl CR; Hanesworth JM; Cushing LL; Harding JW
    J Neurochem; 1987 Aug; 49(2):651-4. PubMed ID: 3598591
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Possible implication of peptidase activity in different potency of angiotensins II and III for displacing [125I]angiotensin II binding in pig aorta.
    Fujimoto M; Mihara S; Shigeri Y; Itazaki K
    Eur J Pharmacol; 1992 May; 215(2-3):259-64. PubMed ID: 1396989
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tachyphylaxis of dipsogenic activity to intracerebroventricular administration of angiotensins.
    Quirk WS; Wright JW; Harding JW
    Brain Res; 1988 Jun; 452(1-2):73-8. PubMed ID: 3401750
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intracerebroventricularly applied peptidase inhibitors increase endogenous angiotensin levels.
    Batt CM; Jensen LL; Hanesworth JM; Harding JW; Wright JW
    Brain Res; 1990 Oct; 529(1-2):126-30. PubMed ID: 2282487
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Manipulation of aminopeptidase activities: differential effects on iontophoretically applied angiotensins in rat brain.
    Felix D; Harding JW
    J Hypertens Suppl; 1986 Dec; 4(6):S398-401. PubMed ID: 3475424
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of low molecular weight peptides and divalent cations on degradation and binding of angiotensin II.
    Nomura S; Mizutani S; Kurauchi O; Kasugai M; Narita O; Tomoda Y
    Horm Metab Res; 1990 Aug; 22(8):444-8. PubMed ID: 2227802
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drinking to intracerebroventricularly infused angiotensin II, III, and IV in the SHR.
    Wright JW; Roberts KA; Harding JW
    Peptides; 1988; 9(5):979-84. PubMed ID: 3244565
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of peptidase inhibition on angiotensin receptor agonist and antagonist potency in rabbit isolated thoracic aorta.
    Robertson MJ; Cunoosamy MP; Clark KL
    Br J Pharmacol; 1992 May; 106(1):166-72. PubMed ID: 1354540
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.